Skip to content

Veradermics

US · MANE #2148 by market cap Listed 2026
119.52 -4.87 -3.92%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Quant vs Street three independent views, side by side

Momentum strategy signal
Hold
Analyst consensus
Buy

Signals diverge - worth digging into why.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 3 analysts

Buy
Avg price target 180.67 +51.2%
Price target rangecurrent 119.52
Low175.00
Avg180.67
High185.00
Buy 100% Hold 0% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-13 Leerink Partners -- Buy 185.00
2026-11-10 Citi -- Buy 175.00
2026-11-09 Citi -- Buy 175.00
2026-11-09 Leerink Partners -- Buy 150.00
2026-10-19 Citi -- Buy 160.00
2026-10-15 Citi -- Buy 160.00
2026-09-15 Citi -- Buy 160.00
2026-09-10 Citi -- Buy 160.00
2026-09-08 Jefferies -- Buy 182.00
2026-08-13 Citi -- Buy 160.00
2026-08-12 Needham -- Buy 164.00
2026-08-11 LifeSci Capital -- Buy 170.00
2026-07-18 LifeSci Capital -- Buy 170.00
2026-07-16 Citi -- Buy 160.00
2026-07-15 LifeSci Capital -- Buy 170.00
2026-07-15 Needham -- Buy 164.00
2026-07-15 B. Riley Securities -- Buy 170.00
2026-06-22 Citi -- Buy 135.00
2026-06-18 Citi -- Buy 135.00
2026-06-16 LifeSci Capital -- Buy 135.00
2026-06-02 Needham -- Buy 136.00
2026-05-18 Citi -- Buy 135.00
2026-05-14 Jefferies -- Buy 138.00
2026-05-01 Citi -- Buy 120.00
2026-04-28 Citi -- Buy 120.00

Price target trend monthly average, last 3 years

Quote time 2026-11-20 20:02:23 · For reference only, not investment advice and not tailored to your situation.

Veradermics discussion 0 comments

Add a comment